To examine the magnitude and types of hospitalizations among persons with prediabetes, undiagnosed diabetes, and diagnosed diabetes.
The burden of diabetes and prediabetes in the U.S. is high (1, 2) . Approximately 21 million adults aged 20 years or older had either diagnosed or undiagnosed diabetes in 2010 (1) . Diabetes represents a significant and increasing proportion of U.S. health care costs (3, 4) . In 2012, the total estimated cost of diagnosed diabetes was 245 billion dollars (compared with 174 billion dollars in 2007) (5, 6) . Overall, inpatient hospitalizations account for the majority of all medical expenditures (7) . Indeed, the largest component of diabetes-related medical expenditures in 2012 was related to inpatient hospital care, which comprised ;43% of the total estimated cost (5) . However, the magnitude of risk of all-cause hospitalization and the different causes of hospitalizations that occur among persons with prediabetes and persons with diabetes are not well characterized.
The objective of this study was to examine the relationships between prediabetes, undiagnosed diabetes, and diagnosed diabetes with all-cause and cause-specific hospitalizations occurring over a median of 20 years of follow-up among middle-aged white and black persons in the community-based Atherosclerosis Risk in Communities (ARIC) study and to evaluate possible interactions by age, race, and sex. We hypothesized that persons with prediabetes, undiagnosed diabetes, and diagnosed diabetes would have higher rates of hospitalization, especially from cardiovascular causes, than those without diabetes and that, in addition to endocrine causes, infectious and iatrogenic/ injury (e.g., postoperative complications, fractures, etc.) causes would represent a substantial burden of hospitalizations among persons with diabetes. We further hypothesized that among persons with diagnosed diabetes, higher HbA 1c ($7.0%) would be associated with higher rates of all-cause hospitalization compared with those with lower HbA 1c (,7 .0%).
RESEARCH DESIGN AND METHODS

Study Population
The ARIC study population is comprised of an ongoing, prospective cohort of 15,792 participants recruited in 1987-1989 (visit 1) from four sites: suburbs of Minneapolis, MN; Washington County, MD; Forsyth County, NC; and Jackson, MS (8) . Participants have subsequently attended four additional inperson visits in 1990-1992 (visit 2), 1993-1995 (visit 3), 1996-1998 (visit 4), and 2011-2013 (visit 5). The ARIC study has been approved by the institutional review boards of all participating institutions, and all participants gave written informed consent at each study visit.
HbA 1c was first measured at ARIC visit 2; therefore, visit 2 (1990-1992 (reference), 5.7 to ,6.5% (prediabetes), and $6.5% (undiagnosed diabetes) (11) . In our main analysis, participants with diagnosed diabetes were categorized as having HbA 1 c ,7.0 or $7.0% (12, 13) . We additionally performed a sensitivity analysis using an HbA 1c cut point of 8.0% (12, 13) . In supplementary analyses, we classified participants by diabetes/fasting glucose category. Participants without a history of diagnosed diabetes were classified as follows: ,100 mg/dL (reference), 100 to ,126 mg/dL (prediabetes), and $126 mg/dL (undiagnosed diabetes) (11) . Participants with diagnosed diabetes were classified as having fasting glucose ,150 or $150 mg/dL.
Ascertainment of Hospitalizations and Definition of Hospitalization Categories
We used data that the ARIC study ascertained through hospitalization reports from annual telephone contact with study participants and through active surveillance of hospitalizations occurring in the study community hospitals. For the current study, follow-up was available from baseline through 31 December 2011. The first ICD-9 code listed in the hospital discharge documentation defined the primary cause for hospitalization.
Our main outcome was counts of allcause hospitalizations. We categorized the primary cause of each hospitalization using the Clinical Classification Software developed by the Agency for Healthcare Research and Quality (https:// www.hcupus.ahrq.gov/toolssoftware/ccs/ ccs.jsp) (14) . The primary cause of each hospitalization was classified into 18 systems-based categories and then subclassified into 285 disease-based categories (14) . In sensitivity analyses, we recategorized all infection-related ICD-9 diagnoses to create a more comprehensive infection category, as not all ICD-9 codes that identified infection were classified in the infection category as defined by the Clinical Classification Software (for example, pneumonia was classified under the respiratory system and not the infection category with use of the Clinical Classification Software). ) was an offset variable, which serves to account for the competing risk of death. The negative binomial model was preferred over the Poisson model for our data due to overdispersion (likelihood ratio test of a = 0 was significant at P , 0.001). We tested for linear trend across the median of the diabetes/HbA 1c categories. In additional sensitivity analyses, we also considered zero-inflated negative binomial models to calculate adjusted rates of hospitalization per 1,000 person-years (95% CI) by diabetes/HbA 1c category because 23% of our population was never hospitalized during follow-up. Akaike information criterion and the Vuong test were used to assess goodness of fit for our models. In additional sensitivity analyses, we used negative binomial regression models to calculate adjusted rates of hospitalization per 1,000 personyears (95% CI) when all continuous covariates were set to mean values and all categorical covariates were set to the reference group by diabetes/fasting glucose category. We formally tested for multiplicative interaction by age, race, and sex in our main statistical models.
Statistical Analyses
All covariates used in statistical models were assessed at visit 2 (1990-1992 All reported P values were based on two-sided tests, and P , 0.05 was considered statistically significant. Analyses were performed using Stata, version 13 (StataCorp, College Station, TX).
RESULTS
Baseline characteristics (ARIC visit 2, [1990] [1991] [1992] .7% for follow-up times of both 5 and 10 years). In sensitivity analyses looking at the impact of diabetes duration, diabetes duration was moderately associated with risk of hospitalization, but this result was not significant at the P = 0.05 level (P = 0.102). The primary causes for hospitalization are shown according to history of diagnosed diabetes status in Fig. 2 . Cardiovascular disease was the most common primary cause for hospitalization among those with and without a history of diagnosed diabetes in (crude rate 174.9 [95% CI 169.5-180.4] and 63.9 [95% CI 62.9-65.0] hospitalizations per 1,000 person-years, respectively, P , 0.001); however, the most common specific cardiovascular diagnosis was coronary atherosclerosis for those without a history of diagnosed diabetes and congestive heart failure for those with diagnosed diabetes (Supplementary Table 5 ). There were significant excess rates of hospitalizations due to cardiovascular, endocrine, respiratory, gastrointestinal, iatrogenic/injury, neoplasm, genitourinary, neurologic, and infection causes among those with diagnosed diabetes compared with those without a history of diagnosed diabetes (all P , 0.05) (Fig. 2) . In sensitivity analyses using a more comprehensive infection category definition, crude rates of hospitalizations with a primary cause of infection were 12.6 (95% CI 12.1-13.1) and 32.4 (95% CI 30.0-35.1) per 1,000 person-years among those without and with a history of diagnosed diabetes, respectively.
CONCLUSIONS
In this community-based population of middle-aged white and black persons, those with prediabetes, undiagnosed diabetes, and diagnosed diabetes had significantly higher rates of all-cause hospitalization over a median of 20 years of follow-up compared with those without a history of diagnosed diabetes and normal Our study is consistent with previous studies that showed high rates of hospitalization among those with diabetes compared with those without diabetes (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) and studies of common causes for hospitalization among those with diabetes (23) (24) (25) 33) . However, in contrast to prior studies (23-25), we did not identify infectious causes as one of the most common causes of hospitalization (infection was ranked tenth). This may be in part due to the ICD-9 code classification system that we used in our primary analyses. While the Clinical Classification Software developed by the Agency for Healthcare Research and Quality (14) does have an infection category, not all ICD-9 codes that identify infection are classified in that category (for example, pneumonia is classified under the respiratory system and not under the infection category). Indeed, when we reclassified all ICD-9 codes that related to infection, we found that hospitalizations among those with diagnosed diabetes due to infectious causes occurred at a rate of 32 per 1,000 person-yearsdresults that are more similar to prior studies (23) (24) (25) .
Prior studies of hospitalization rates in persons with diabetes have been limited by cross-sectional designs (23, 24) , short follow-up (,5 years) (25, 27, (30) (31) (32) , and/or by the use of ICD-9 codes to define diabetes status (23, 24, 26, 27) . Many prior studies also did not compare hospitalization risk in persons with prediabetes or undiagnosed diabetes (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) or evaluate potential differences by age, sex, and race (23) (24) (25) (26) (27) 30, 31) . Our study had a median follow-up period of 20 years in a community-based population, and we were able to rigorously characterize and compare hospitalization risk among those with diagnosed diabetes by levels of HbA 1c and in those at high risk prior to a formal diagnosis of diabetes (prediabetes and undiagnosed diabetes). Our results extend the literature by showing not only that diagnosed diabetes is associated with a higher risk of hospitalization but also that prediabetes and undiagnosed diabetes were associated with a significant excess rates of hospitalization later in life. Consistent with prior studies establishing that poorer glycemic control in midlife is associated with an increased risk of complications and mortality (21, (34) (35) (36) , we found that higher HbA 1c values in persons with diagnosed diabetes were an important indicator of future hospitalization risk later life. Our results suggest that prevention of diabetes and improved management of diabetes could impact later-life hospitalization risk.
Certain limitations should be taken into consideration in the interpretation of this study. First, although we ascertained hospitalization data via both annual telephone contact with study participants and active surveillance of hospitalizations occurring in all study communities, some hospitalizations occurring among ARIC participants (e.g., hospitalizations outside of the surveillance areas that are not reported during follow-up telephone calls) are likely not captured in our data. Therefore, our results likely underestimate the true rates of hospitalization in our population. Second, we only had one measure of HbA 1c , and we were thus unable to apply timevarying diabetes/HbA 1c categories over follow-up. However, in sensitivity analyses where follow-up time was limited to 5 and 10 years after baseline, rates of all-cause hospitalization remained significantly higher for those with prediabetes and undiagnosed diabetes compared with those with normoglycemia, suggesting that prediabetes and undiagnosed diabetes represent groups at high risk that is not fully explained by a later diagnosis of diabetes. We also did not have detailed data on diabetes duration. However, we were able to look at diabetes duration split at 3 years (,3 years [diagnosed with diabetes between ARIC visits 1 and 2] vs. .3 years [diagnosed with diabetes prior to ARIC visit 1]), which was not significantly associated with hospitalization. Additionally, we observed differential mortality by diabetes/HbA 1c category. Therefore, our relative hospitalization rates are likely an underestimation due to competing mortality risk, but we did include follow-up time as an offset variable in our regression models, which served as a means to account for this competing risk of death. The ARIC study was recruited from four U.S. communities and therefore may not be representative of the entire U.S. population. Further, all participants in the ARIC study were given the option to have their primary care doctor notified if lab results were abnormal; therefore, ARIC participants may receive a diagnosis of diabetes at an earlier point than persons in the general community as a result of being in the study. However, an analysis in ARIC study participants showed that diagnosis of diabetes was still delayed on average by 2-7 years after the study visit at which the glucose was elevated (37) .
In conclusion, in this communitybased longitudinal study, we found that middle-aged persons with prediabetes or diabetes had significantly excess rates of hospitalization during two decades of follow-up. Randomized clinical trials of glucose control have typically enrolled high-risk patients, have had limited follow-up, and have focused on narrowly defined microvascular and/or macrovascular outcomes. Observational cohort studies, such as ours, can provide comprehensive evidence of the long-term risks of hyperglycemia. We found an excess risk of total hospitalizations, and cardiovascular hospitalization in particular, not only among persons with diagnosed diabetes and poorly controlled diabetes but also among those with undiagnosed diabetes and prediabetes. Our results suggest that prevention of prediabetes from progression to overt diabetes and improved glycemic control among those with diagnosed diabetes may reduce the burden of hospitalizations over the life span. The high rate of hospitalization due to endocrine, infection, and iatrogenic/injury causes among those with diagnosed diabetes is concerning and suggests that increased efforts are needed to reduce the burden of preventable hospitalization among persons with diabetes.
